Definium Therapeutics, Inc. · NASDAQ:DFTX
Wiley Matthew T. received 125,000 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 14, 2026 · Filed Sep 14, 2026
On Sep 14, 2026, Wiley Matthew T. (Chief Commercial Officer) received 125,000 Definium Therapeutics, Inc. shares as an award, leaving 362,133 shares. Filed Sep 14, 2026 (Form 4).
- Awarded
- 125,000 shares
- Holding after
- 362,133 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Shares | Award | 125,000 | 362,133 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Wiley Matthew T.
- Definium Therapeutics, Inc. shareholders
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Aug 12, 2026
- Form 4 · Wiley Matthew T. · Jun 26, 2026
- Form 4 · Wiley Matthew T. · Jun 22, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026